PL413054A1 - Bacteriophage strain and its application for treatment of infections evoked by Proteus mirabilis bacteria, preferably by drug-resistant strains - Google Patents

Bacteriophage strain and its application for treatment of infections evoked by Proteus mirabilis bacteria, preferably by drug-resistant strains

Info

Publication number
PL413054A1
PL413054A1 PL413054A PL41305415A PL413054A1 PL 413054 A1 PL413054 A1 PL 413054A1 PL 413054 A PL413054 A PL 413054A PL 41305415 A PL41305415 A PL 41305415A PL 413054 A1 PL413054 A1 PL 413054A1
Authority
PL
Poland
Prior art keywords
proteus mirabilis
bacteriophage
bacteriophage strain
drug
treatment
Prior art date
Application number
PL413054A
Other languages
Polish (pl)
Other versions
PL228858B1 (en
Inventor
Agnieszka Maszewska
Antoni Różalski
Original Assignee
Uniwersytet Łódzki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Łódzki filed Critical Uniwersytet Łódzki
Priority to PL413054A priority Critical patent/PL228858B1/en
Priority to SI201630733T priority patent/SI3319626T1/en
Priority to PL16753961T priority patent/PL3319626T3/en
Priority to EP16753961.8A priority patent/EP3319626B1/en
Priority to US15/742,127 priority patent/US10435671B2/en
Priority to PCT/IB2016/000974 priority patent/WO2017006175A1/en
Priority to DK16753961.8T priority patent/DK3319626T3/en
Publication of PL413054A1 publication Critical patent/PL413054A1/en
Publication of PL228858B1 publication Critical patent/PL228858B1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem wynalazku jest nowy szczep bakteriofagowy i jego zastosowanie do produkcji preparatów stosowanych w leczeniu lub zapobieganiu zakażeniom bakteryjnym i zwalczaniu biofilmów, zwłaszcza szczepami bakterii lekoopornych z gatunku Proteus mirabilis. Nowy szczep bakteriofaga specyficzny wobec bakterii należących do gatunku Proteus mirabilis zdeponowany jest w Polskiej Kolekcji Mikroorganizmów (PCM) pod numerem depozytowym: F/00085. Zastosowanie szczepu bakteriofaga dotyczy użycia całego bakteriofaga w preparatach złożonych z pojedynczego typu faga, jak i w postaci koktajlu zawierającego kilka lub kilkanaście aktywnych bakteriofagów. Ponadto wynalazek obejmuje wykorzystanie oczyszczonych białek bakteriofagowych, korzystnie enzymów litycznych degradujących ścianę komórkową bakterii oraz rozkładających bakteryjne polisacharydy zewnątrzkomórkowe.The subject of the invention is a new bacteriophage strain and its use in the production of preparations used in the treatment or prevention of bacterial infections and combating biofilms, especially strains of drug-resistant bacteria of the species Proteus mirabilis. A new bacteriophage strain specific for bacteria belonging to the species Proteus mirabilis is deposited in the Polish Collection of Microorganisms (PCM) under deposit number: F / 00085. The use of the bacteriophage strain refers to the use of the entire bacteriophage in preparations consisting of a single type of phage, as well as in the form of a cocktail containing several or several active bacteriophages. Furthermore, the invention includes the use of purified bacteriophage proteins, preferably lytic enzymes that degrade the bacterial cell wall and degrade bacterial extracellular polysaccharides.

PL413054A 2015-07-07 2015-07-07 Bacteriophage strain and its application for treatment of infections evoked by Proteus mirabilis bacteria, preferably by drug-resistant strains PL228858B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PL413054A PL228858B1 (en) 2015-07-07 2015-07-07 Bacteriophage strain and its application for treatment of infections evoked by Proteus mirabilis bacteria, preferably by drug-resistant strains
SI201630733T SI3319626T1 (en) 2015-07-07 2016-07-07 Bacteriophage strains against proteus mirabilis and uses thereof
PL16753961T PL3319626T3 (en) 2015-07-07 2016-07-07 Bacteriophage strains against proteus mirabilis and uses thereof
EP16753961.8A EP3319626B1 (en) 2015-07-07 2016-07-07 Bacteriophage strains against proteus mirabilis and uses thereof
US15/742,127 US10435671B2 (en) 2015-07-07 2016-07-07 Bacteriophage strains against proteus mirabilis and use thereof
PCT/IB2016/000974 WO2017006175A1 (en) 2015-07-07 2016-07-07 New bacteriophage strains against proteus mirabilis and use thereof
DK16753961.8T DK3319626T3 (en) 2015-07-07 2016-07-07 Bacteriophage strains against Proteus mirabilis and their applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL413054A PL228858B1 (en) 2015-07-07 2015-07-07 Bacteriophage strain and its application for treatment of infections evoked by Proteus mirabilis bacteria, preferably by drug-resistant strains

Publications (2)

Publication Number Publication Date
PL413054A1 true PL413054A1 (en) 2017-01-16
PL228858B1 PL228858B1 (en) 2018-05-30

Family

ID=57756392

Family Applications (1)

Application Number Title Priority Date Filing Date
PL413054A PL228858B1 (en) 2015-07-07 2015-07-07 Bacteriophage strain and its application for treatment of infections evoked by Proteus mirabilis bacteria, preferably by drug-resistant strains

Country Status (1)

Country Link
PL (1) PL228858B1 (en)

Also Published As

Publication number Publication date
PL228858B1 (en) 2018-05-30

Similar Documents

Publication Publication Date Title
PH12021550931A1 (en) New anthelmintic compounds
PH12019501557A1 (en) Bacillus isolates and uses thereof
PH12019500714A1 (en) Antiseptic-tolerant lactic acid bacteria
ZA202002093B (en) Antibacterial compounds
PH12017501169A1 (en) Bacillus licheniformis rti184 compositions and methods of use for benefiting plant growth
NZ630117A (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
MX2018001075A (en) Antibacterial therapeutics and prophylactics.
MX2017012545A (en) Heterocyclic compounds and their use in preventing or treating bacterial infections.
UA111210C2 (en) ANTIBACTERIAL 3,4-DIGIDRO-1H- [1,8] NAFTYRIDINONS, CYCLOPENT SUBSTITUTED [C] PYROM
WO2015112980A3 (en) Dermaseptin-type and piscidin-type antimicrobial peptides
MX2020006191A (en) Therapeutic bacteriocins.
ZA202006612B (en) Antibacterial compounds
MY195904A (en) Indolinones Compounds and Their use in the Treatment Of Fibrotic Diseases
MX2017012535A (en) Novel heterocyclic compounds and their use in preventing or treating bacterial infections.
MX2022006109A (en) 1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors.
EA201890412A1 (en) ANTIBACTERIAL AGENTS CONTAINING PIRAZINO [2,3-b] [1,4] OXAZIN-3-IT OR RELATED RING SYSTEM
AU2012335397A8 (en) Novel bacteriophages
BR112021015638A2 (en) Methods, compositions containing bacillus-producing bacteria or preparations thereof
PL386175A1 (en) New strains of bacteriophages for treatment of bacterial infections, preferably by means of the strains of drug-resistant bacterias of the Enterococcus type
MX363480B (en) New antibacterial compounds.
MA39024A1 (en) Bacillus subtilis strain deposited under the deposit number cect 8258 and method of protection or treatment of plants
PH12021552133A1 (en) Aromatic derivatives, preparation methods, and medical uses thereof
MX2017012539A (en) Heterocyclic compounds and their use in preventing or treating bacterial infections.
PL413052A1 (en) Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strains
MX2023006231A (en) Enzyme inhibitors.